ViroGates A/S
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic he… Read more
ViroGates A/S (VIRO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.879x
Based on the latest financial reports, ViroGates A/S (VIRO) has a cash flow conversion efficiency ratio of -0.879x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-2.49 Million) by net assets (Dkr2.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ViroGates A/S - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how ViroGates A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ViroGates A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ViroGates A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Techcential International Ltd
TWO:6616
|
0.001x |
|
White Energy Company Limited
PINK:WECFF
|
0.030x |
|
Blackbird Critical Metals Corp
OTCQB:BBCMF
|
-0.048x |
|
AMEN Properties Inc
PINK:AMEN
|
0.097x |
|
GROUNDS R.EST. NA O.N.
F:AMMN
|
N/A |
|
Paranapanema S.A
SA:PMAM3
|
-0.002x |
|
Smart Gunes Enerjisi Teknolojileri Arastirma Gelistirme Uretim Sanayi ve Ticaret
IS:SMRTG
|
0.134x |
|
Chia Yi Steel Co Ltd
TWO:2067
|
0.005x |
Annual Cash Flow Conversion Efficiency for ViroGates A/S (2015–2024)
The table below shows the annual cash flow conversion efficiency of ViroGates A/S from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Dkr10.79 Million | Dkr-11.95 Million | -1.107x | -54.56% |
| 2023-12-31 | Dkr17.01 Million | Dkr-12.18 Million | -0.716x | +19.30% |
| 2022-12-31 | Dkr16.09 Million | Dkr-14.28 Million | -0.887x | +32.01% |
| 2021-12-31 | Dkr16.43 Million | Dkr-21.44 Million | -1.305x | -161.93% |
| 2020-12-31 | Dkr31.31 Million | Dkr-15.60 Million | -0.498x | -16.38% |
| 2019-12-31 | Dkr42.22 Million | Dkr-18.07 Million | -0.428x | -59.46% |
| 2018-12-31 | Dkr61.01 Million | Dkr-16.38 Million | -0.268x | +87.07% |
| 2017-12-31 | Dkr3.00 Million | Dkr-6.22 Million | -2.077x | -179.46% |
| 2016-12-31 | Dkr8.98 Million | Dkr-6.68 Million | -0.743x | -60.13% |
| 2015-12-31 | Dkr14.39 Million | Dkr-6.68 Million | -0.464x | -- |